To test this hypothesis, we conducted a meta-analysis on genetic alterations in LEP and ADIPOQ genes as well as their receptor-encoded genes by pooling published summary data, aiming to evaluate their association with risk for breast cancer, as well as circulating leptin and adiponectin levels. The gene discussed is LEP; the disease is breast carcinoma.